UCL researchers, UCLH clinicians and industry peers gather together to praise the past and look forward to the future
In the same month that the Institute of Nuclear Medicine, University College Hospital (UCH) took delivery of a Biograph™ mMR hybrid molecular MR system from Siemens Healthcare, luminaries from the field of nuclear medicine gathered together to celebrate fifty years of scientific discovery. A 50th anniversary lecture was held to pay tribute to the work of the Institute over the past five decades in unlocking medical advancements through the work of UCL researchers and UCLH clinicians.
The Biograph mMR – which will be housed in the UCH Macmillan Cancer Centre when it opens next year – is the latest advance in nuclear medicine. It will be the first in the UK and one of the first in Europe. It will be used for diagnostic and patient treatment planning, and for research purposes.
The guest of honor at the Institute of Nuclear Medicine’s 50th anniversary was Bruce Rosen, Professor of Radiology, Health Sciences and Technology at Harvard Medical School who gave a lecture on ‘PETMR and its Future’ promoting the power of combined PET and MR.
Dr Jamshed Bomanji, UCLH Nuclear Medicine Consultant and Head of Department said, “The Institute started 50 years ago with a single counting probe. Today, after five decades it is one of the largest teaching and servicing hospital departments and has state-of-the-art equipment and an international reputation. This is all thanks to the staff and charities who have supported the institute over the five decades.”
UCLH chairman, Richard Murley thanked UCLH Charity for funding the Siemens Biograph mMR scanner. He added that the institute was one of the “most significant manifestations of the strong link between the hospital Trust and the university”.
Professor Peter Ell, Emeritus Professor, former Head of the Institute of Nuclear Medicine and Senior Investigator of the National Institute of Health Research spoke during the evening about the highlights of each decade since the Institute’s conception. This included the designing and testing of the first European nuclear medicine brain scanner in the 70s; design and testing of the first dedicated mobile renal function apparatus in the 80s; through to introducing PET CT in cancer management; and moving to the new UCH, commissioning a new radiochemistry laboratory and expanding the therapy program.
Lawrence Foulsham, Molecular Imaging Product Manager at Siemens Healthcare comments, “Siemens is delighted to have attended the 50th anniversary celebrations of the Institute of Nuclear Medicine and look forward to the contributions that our hybrid molecular MR innovation will bring into the future.”
About Siemens Healthcare
The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimising clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 48,000 employees worldwide and operates around the world. In fiscal year 2010 (to September 30), the Sector posted revenue of 12.4 billion euros and profit of around 750 million euros. For further information please visit: www.siemens.com/healthcare.
For more information please contact:
Georgina Wright / Jon Wilcox
T: 01225 471202
T: 01276 696374